Nature Communications (May 2016)

Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells

  • Kerstin Göbel,
  • Susann Pankratz,
  • Chloi-Magdalini Asaridou,
  • Alexander M. Herrmann,
  • Stefan Bittner,
  • Monika Merker,
  • Tobias Ruck,
  • Sarah Glumm,
  • Friederike Langhauser,
  • Peter Kraft,
  • Thorsten F. Krug,
  • Johanna Breuer,
  • Martin Herold,
  • Catharina C. Gross,
  • Denise Beckmann,
  • Adelheid Korb-Pap,
  • Michael K. Schuhmann,
  • Stefanie Kuerten,
  • Ioannis Mitroulis,
  • Clemens Ruppert,
  • Marc W. Nolte,
  • Con Panousis,
  • Luisa Klotz,
  • Beate Kehrel,
  • Thomas Korn,
  • Harald F. Langer,
  • Thomas Pap,
  • Bernhard Nieswandt,
  • Heinz Wiendl,
  • Triantafyllos Chavakis,
  • Christoph Kleinschnitz,
  • Sven G. Meuth

DOI
https://doi.org/10.1038/ncomms11626
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 16

Abstract

Read online

Factor XII initiates the intrinsic blood coagulation cascade and the kinin system. Here the authors show that Factor XII is elevated in the blood of multiple sclerosis patients, activates dendritic cells via CD87 and cAMP, and its blockade inhibits immunopathology in a mouse model of the disease.